BMB-01 - Reaches PHASE-2 Clincal Trials.

away

away

6’1
Joined
Aug 7, 2024
Posts
172
Reputation
136
New breakthrough experimental Oral drug BMB-01 (Bright Minds Biosciences) reaches phase-2 clinical trials.

BMB-101 works by targeting a specific receptor in the brain called the 5-HT₂C serotonin receptor. Serotonin is a chemical messenger that affects mood, appetite (Reducing your appetite), and brain activity. BMB-101 is not a stimulant. By carefully activating this specific receptor, BMB-101 aims to help calm abnormal brain activity that can lead to seizures. It also nearly doubles the amount of REM Sleep a person gets throughout the night, looking at a 90% Increase in REM Sleep (BioSpace, 2026).

Although BMB-101 looks promising, it is still being studied and has not yet been approved for public use. Many drugs seem successful in early testing but need more research to prove they are safe and effective in the long term.

Hopefully it passes Phase 2 Clincal Trials and reaches the public.
 
  • +1
Reactions: recessed55 and Rylie
More trials May lead to this information being changed since its still new.
 
I saw that TikTok too nigga
 
  • +1
Reactions: qxdr
New breakthrough experimental Oral drug BMB-01 (Bright Minds Biosciences) reaches phase-2 clinical trials.

BMB-101 works by targeting a specific receptor in the brain called the 5-HT₂C serotonin receptor. Serotonin is a chemical messenger that affects mood, appetite (Reducing your appetite), and brain activity. BMB-101 is not a stimulant. By carefully activating this specific receptor, BMB-101 aims to help calm abnormal brain activity that can lead to seizures. It also nearly doubles the amount of REM Sleep a person gets throughout the night, looking at a 90% Increase in REM Sleep (BioSpace, 2026).

Although BMB-101 looks promising, it is still being studied and has not yet been approved for public use. Many drugs seem successful in early testing but need more research to prove they are safe and effective in the long term.

Hopefully it passes Phase 2 Clincal Trials and reaches the public.
How does this compare to something like agomelatine. They seem kinda similar despite doing basically completely opposite things.
 
How does this compare to something like agomelatine. They seem kinda similar despite doing basically completely opposite things.
They act on the same serotonin receptor (5-HT₂C) but in opposite ways.
  • BMB-101 - Activates (stimulates) the 5-HT₂C receptor - calming excessive brain firing
  • Agomelatine - Blocks the 5-HT₂C receptor - Used to treat depression and improve mood and sleep
They have similar affects but are used for different purposes since BMB-01 is also used to reduce seizures. I think the main difference is BMB-01 Calms the brain down and reduces activity while Agomelatine allows more dopamine activity.
 
  • +1
Reactions: recessed55

Similar threads

pio
Replies
2
Views
74
nakus
nakus
M
Replies
12
Views
560
gonialangle1
gonialangle1
egorkrasnov
Replies
3
Views
201
PharmaPhaggot
PharmaPhaggot
alexias
Replies
67
Views
5K
alexias
alexias

Users who are viewing this thread

Back
Top